Dr. Yasir Al-Khalili, MD

Dr. Al-Khalili practices at Signify Health in Campbell, California.

Dr. Al-Khalili's NPI, 1730528159, was assigned on June 19, 2013. Dr. Al-Khalili graduated from St. George's University School of Medicine in 2013. Dr. Al-Khalili holds Virginia license 0101265579.

Dr. Al-Khalili's primary practice is Signify Health, at 900 E Hamilton Ave, Campbell, CA 95008 in Santa Clara County. The practice phone is (469) 466-7007.

Dr. Al-Khalili's primary practice is Signify Health in Campbell, California. Dr. Al-Khalili is also affiliated with MedStar Washington Hospital Center. The medical group on file is Signify Health. Dmand AI also links Dr. Al-Khalili to 2 more hospitals, 5 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Khalili practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Al-Khalili's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Al-Khalili is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Al-Khalili's licenses on file in 5 states: Virginia, District of Columbia, Maryland, North Carolina and Pennsylvania.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy and hypersomnia among the conditions Dr. Al-Khalili treats.

CMS data shows 684 Medicare services from Dr. Al-Khalili across 10 procedure codes in 2024, for 309 Medicare patients. Medicare paid $61,552 for them.

CMS counts 309 Medicare patients who saw Dr. Al-Khalili in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 50% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Khalili's median patient age at 62, with 61% women.

In 2024, Dr. Al-Khalili wrote 496 Medicare Part D claims for 193 patients. 89% of them were for generic drugs. CMS names the drug for 306 of them, across 16 drugs with 11 or more claims each, at $252,940 in total drug cost. In 2023, CMS named 1,870 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Al-Khalili for performance year 2024, reported as part of a group. Dr. Al-Khalili accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Al-Khalili as offering telehealth.

CMS Open Payments shows 250 general payments to Dr. Al-Khalili from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Janssen Pharmaceuticals, Inc paid the most, $46,346.

Dr. Al-Khalili graduated from St. George's University School of Medicine in 2013. Dr. Al-Khalili is a member of AAN.

Dr. Al-Khalili is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.